Today is: Thursday, July 24, 2008 Neotrope®
Press Release Writing and News Distribution
Send2Press® - Press Release Writing, Targeted News Distribution and Media Relations since 1983 press release writing and distribution services from send2press
Newswire Services Press Release Writing Order Send2Press Services
Affordable Newswire Services and Targeted Distribution
BUSINESS WEB WIRE PR NEWSWIRE SERVICES
Press Release Distribution
PR Services
 Site Search:     
Translate Page:

U.S. and World Newswire : Medical : Drugs and Pharmaceuticals News


OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research

Published: Thu, 11 Oct 2007, 20:58:00 EDT
Edited by Liisa Sullivan Email this article Print this news article Share Content


RICHMOND, Texas - Oct. 11 (SEND2PRESS NEWSWIRE) -- OCuSOFT Inc., producer of the popular ocular-lid hygiene products, OCuSOFT(R) Lid Scrub(TM) and OCuSOFT(R) Lid Scrub(TM) PLUS, is responding to a recent advertisement released by Advanced Vision Research (AVR) that was found to be misleading.

The study, a bacteria time-kill analysis, compared OCuSOFT's Lid Scrub(TM) PLUS Eyelid Cleanser to AVR's SteriLid(R). However, according to OCuSOFT's Executive Vice President, Patrick Witham, "comparing the bacteria kill rate for these two products based on 30-second time point is like comparing apples to oranges." In addition, no evidence was found in AVR's analysis that results were based on independent-lab setting tests.

While both products are eyelid cleansers, they differ in their application and the time in which each product achieves maximum effectiveness. OCuSOFT(R) Lid Scrub(TM) PLUS can be used as a leave-on therapy, while SteriLid(R), according to manufacturer instructions, should be left in place for 60-seconds to achieve maximum effectiveness.

The AVR advertisement compared OCuSOFT(R) Lid Scrub(TM) PLUS and SteriLid(R) at the 30-second time point.

"Unlike SteriLid(R), OCuSOFT(R) Lid Scrub(TM) PLUS was never intended to achieve maximum effectiveness at 30-seconds," Witham said.

OCuSOFT conducted their own study, performed by an independent laboratory, Antimicrobial Test Laboratories, LLC, which tested OCuSOFT(R) Lid Scrub(TM) PLUS after 60-seconds, 60-minutes and 120-minutes. Bacteria reductions were greatest at contact times corresponding with instructions for "leave-on" application. At 120-minutes, at least a 99.9% bacteria reduction was realized on all bacteria, and for some, as much as 99.99%.

For comprehensive, independent laboratory study results, visit: www.ocusoft.com/studies/studyresults.html.

"For a true comparison," Witham explained, "AVR should have compared OCuSOFT(R) Lid Scrub(TM) PLUS at the 120-minute time point to SteriLid(R) at the 60-second time point." They would have found that OCuSOFT(R) is more effective.

OCuSOFT(R) Lid Scrub(TM) PLUS was developed with an understanding that most patients, and even health care providers, will not spend 60-seconds applying a solution and rinsing it off.

Emily Sickbert-Bennet, a public health epidemiologist with the University of North Carolina Health Care System and the UNC School of Public Health conducted a study that illustrates that, on average, health care providers spend less than 10-seconds scrubbing their hands.

"This is important information that should not be dismissed. The parallels that can be drawn between these hygiene regimens speak volumes about the likelihood of a patient realistically complying with a 60-second eyelid scrubbing regimen," Witham said. "We developed this practically non-irritating formula in an effort to increase patient compliance. What good is served by recommending a regimen that patients will not adhere to?"

OCuSOFT, Inc. specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They address clinical needs through well-researched and technological solutions, while improving patient compliance.

For a free sample of OCuSOFT(R) Lid Scrub(TM) PLUS, click: www.ocusoft.com/sample1.html.

For more information about the company and their products, visit: www.ocusoft.com.

All trademarks acknowledged.


  NEWS SOURCE:  OCuSOFT, Inc.
 Send2Press® is the originating wire service for this story.

» Read More Drugs and Pharmaceuticals News
» Other Send2Press Industry News by Category

More Information and Media Contact:
For questions about this story, contact the news source:
» Click Here for Contact Information
THE CONTENT OF THE ABOVE NEWS STORY WAS PROVIDED BY THE NEWS SOURCE WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT SEND2PRESS (THIS WEBSITE).

R E A D E R   R E S O U R C E S
» E-mail This Article    » Printer-Friendly Version
» Choose RSS News Feeds by Topic
 Subscribe in a reader
Add News to Google   Add News to My Yahoo!   Add News to MyMSN   Add to My Wikio

Bookmark and/or share this content with your social network:
del.icio.us:OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research  digg:OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research  blinklist:OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research  furl:OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research  blogmarks:OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research  reddit:OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research  Y!:OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research    Add to Mixx!

» Permalink for This Article
[ http://www.send2press.com/newswire/2007-10-1011-003.shtml ]


ADDITIONAL NEWS FROM
OCuSOFT, Inc.

» CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies

» OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research

» CYNACON/OCuSOFT (OCuSOFT, Inc.) Names Katherine M. Mastrota, M.S., O.D. to Medical Scientific Advisory Board

» CYNACON/OCuSOFT (OCuSOFT, Inc.) Names Edward J. Holland, M.D. to Medical Scientific Advisory Board

» Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product

» More Drugs and Pharmaceuticals News  » Top of Page  » Home

J O U R N A L I S T   R E S O U R C E S

Media Copy of Original Press Release:
Plain Text Copy of News Article  PLAIN TEXT FORMAT (UTF-8)      PDF Text Copy of News Article  PDF FORMAT

» Weekly E-Mail News Summary    » RSS Feeds by Topic
» Add Our Headlines to Your Site Automatically (FREE)

Find More News Content About
OCuSOFT, Inc.

 Site Search:     


O T H E R   R E S O U R C E S
Business Tools:
» Send Your News to the Media
» Targeted News Distribution
» Press Release Writing and Editing
Webmaster Tools:
» Add Our Headlines to Your Website

 
T E R M S   O F   U S E
This article is Copr. © 1983-2008 Neotrope / Send2Press. Reproduction of this news article version requires written authorization. You may freely link to this article. Journalists (see the section "Journalist Resources" above) may use orig. news release as the basis for an article. News Websites may republish the "news release" text version linked to above under "Journalist Resources" except must retain "Send2Press Newswire" as the source of this news if used verbatim. Websites which offer/sell PR or newswire services, or web promotion services, or "splogs" may NOT reprint our content in ANY form. Send2Press Newswire is a service mark of, and "Send2Press" is a registered trademark of, Neotrope. Creative Commons - Some Rights Reserved (3.0) - Attribution Required.

DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the source (OCuSOFT, Inc.). The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.

REFERENCES: .
VIEWED BY MEDIA (and public): 1253 times (1 today, 15 this week, 65 this month, 761 this year)

Drugs and Pharmaceuticals
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for The Treatment of Osteosarcoma
Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G
CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
Targeted Gene Delivery Signals Cancer Vaccination in Vivo
TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity without Toxicity in Metastatic Pancreatic Cancer
Eularis to Address Marketing Return at Japanese Pharmaceutical Marketing Excellence Conference
Eularis to Address Making the Right Research Decision for ROI
Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy with No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Bros. Movie to be Filmed About Him
Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
Eularis Exposes Hidden Barriers to Patient Adherence with New Pharmaceutical Industry Report
MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
Losing Weight But Still Have Belly Bulge?
Myo-Med, Tom Brady and STG Media Corp. Team Up to Jump Start Myo-Med's 2008 Advertising Campaign
Recent Studies Suggest Popular 'Diet Pill' Reduces Acne Breakouts
deverus, Inc. Partners with eScreen Inc. to Offer First and Only Instrumented Instant Drug Testing Device to Clients
Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G, a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
New Report Examines Pharmaceutical Sales Force Effectiveness
FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
U.S. Pharmaceuticals Spend $8 Billion Annually in R&D Conducted Overseas - New Clintelligence(R) Alignment Module Advances Global Management

» View All News Channels
» Press Release Services
» Send2Press Home Page

U.S. and World Newswire
Millions of Americans Face $100,000-Plus Annual Hit for College and Long-Term-Care Combo
Podclass Announced as Recipient of fbFund for Application Built on Facebook(R) Platform
Renewable Energy Division Created at S+H Construction
New Devices Move Internet Videos Off PCs and Into Homes, Changing TV Forever, says Insight Research
Iglesias Nights - An Evening of Salsa Dancing and Latin Culture in Los Angeles - Giving Back to the Community with a Message of Hope and Success
Power Sports Factory, Inc. Engages American Financial Strategies to Promote Its Line of High Quality, Fuel Efficient, Premium Motorbikes
Get Green with Leader Phone(R) Web 2.0 Audio Conferencing
STG Media Corp and STG Interactive Help Launch Innovative Electro-Magnetic Pain Product in Canada
Mentoring Success Group Launches 'We Mentor Success' Events for Small Businesses
Paramito Global Holdings Announces Investment Activities
Telecom Training For Government Will Stretch Tax Dollars
CareTools Announces iChart Available on Apple App Store
ClusterSeven Releases New Version of its Spreadsheet Monitoring and Control Software
WhiteFlash.com Reaches Big 'O' Status in July
S+H Construction Announces Renewable Energy Division
Red Canyon Pictures Announce a Sneak Peek of Film 'Red Canyon' at HBO Presents: NYLIFF
World's Greatest Endurance Man Attempts Record Breaking Feats in New York City
LTC Financial Partners Named as Long Term Care Insurance Source by Kiplinger's 2nd Year in a Row
Paradigm Multimedia Technology Changes the Rules for Health Care TV Systems
Online Event Registration Equals Success for Event Marketing
PreViser Corporation Appoints Director of Medical Technology to Expand Further into Medicine
MMC Creates Unique Opportunities for Advertisers to Reach Horror Enthusiast
The National Urban and Community Forestry Advisory Council (NUCFAC) Hosts Public Forum on A Comprehensive Look at Tropical Forestry
Popular Orthopedics Medical Handbook Now Available in Portuguese
E-Cap from JAF Industries Can Save Homeowners Thousands of Dollars on a $10 Purchase

» View All News Channels
» Press Release Services
» Send2Press Home Page
Full Text RSS 2.0 news feed RSS 0.91 Summary News Feed Entertainment Podcast RSS Feed
» View Menu of News Feeds by Topic
— ADVERTISEMENT —
Promote Your Company to the Media
and on This Website

Press release services from Neotrope®. Member BBB. Expert PR staff. Targeted solutions since 1983. Learn More
Business News 
 
 U.S. and World Newswire
 Advertising and Marketing
 Aerospace and Aviation
 Agriculture and Farming
 Auction and Online Auctions
 Auto and Motorsports
 Banking and Finance
 Beauty Products
 Boating, Marine and Maritime
 Business
 Communication Arts
 Computing
 Construction and Building
 Corporate Social Responsibility - CSR
 Defense and Military
 Education and Schools
 Electronics
 Employment, HR and Outsourcing
 Energy, Oil and Gas
 Entertainment
 Environment and Ecology
 Facilities and Building Maintenance
 Family, Parenting and Children
 Firearms and Airguns
 Food and Beverages
 General Editorial
 Global Aid and Relief
 Government
 Green Business
 Health, Diet and Fitness
 Home and Garden
 HVAC Heating and Cooling
 Insurance
 Internet and Websites
 Jewelry and Diamond
 Legal and Law
 Manufacturing
 Medical
 Alternative Medicine 
 Biotechnology 
 Cosmetic Surgery 
 Dentistry 
 Devices and Research 
 Disabilities and 508 Compliance 
 Drug Rehabilitation 
 Drugs and Pharmaceuticals 
 Fertility and IVF 
 Hospitals and Nursing 
 Long Term Care 
 Medical and Health Products 
 Medical Business Services 
 Private Practice and Medical Groups 
 Surgery and Neurotechnology 
 Mining and Metals
 NonProfit and Charities
 Plastics and Composites
 Police, Fire and Rescue
 Real Estate
 Regional Events
 Religion and Churches
 Restaurant, Hotel and Hospitality
 Safety and Security Solutions
 Sciences
 Sports and Activities
 Stamps, Coins and Collectables
 Taxes and Accounting
 Telecommunications and VoIP
 Theme Parks and Attractions
 Trade Shows, Fairs and Expos
 Transportation
 Travel and Tourism
 U.S. Companies
 US and World History
 Veterinary and Pets
 
 U.S. State Newswires
 Alabama Business
 Alaska Business
 Arizona Business
 California Business
 Colorado Business
 Connecticut Business
 Florida Business
 Georgia Business
 Hawaii Business
 Idaho Business
 Illinois Business
 Iowa Business
 Kansas Business
 Maryland Business
 Massachusetts Business
 Michigan Business
 Minnesota Business
 Missouri Business
 Nebraska Business
 Nevada Business
 New Jersey Business
 New Mexico Business
 New York Business
 North Carolina Business
 Ohio Business
 Oklahoma Business
 Oregon Business
 Pennsylvania Business
 Puerto Rico Business
 South Carolina Business
 South Dakota Business
 Tennessee Business
 Texas Business
 Utah Business
 Vermont Business
 Virginia Business
 Washington D.C. Business
 Washington State Business
 West Virginia Business
 Wisconsin Business
 
 Video News Releases
 
 World Newswires
 Brazil Business
 Canada Business
 Germany Business
 Spain Business
 United Kingdom

Subscribe to FREE
Send2Press®
Weekly News Alert

» Privacy Statement
» How to Unsubscribe

Click to Hear Podcasts
» Click to Hear Podcasts

Recent Send2Press News Network Placements on:
newswire placement on Google News
Advertising Industry
FURL LookSmart Publishers Newswire
Yahoo! News
Technorati News

INTERNET NEWSWIRE ARCHIVE SPONSORS
Website Promotion Services and SEO PR
Powered by Neotrope®
» View a list of our news archive sponsors
Learn about Send2Press Media Solutions